Impact Rooms
Impact Rooms is a venture capital firm based in Mexico City, Mexico. This profile covers what we know about Impact Rooms and how founders can get in front of it in 2026.
Impact Rooms prepares impact-driven African ventures for growth and investment, then connects them with investors from around the world.
- Location
- Mexico City, Mexico
- Team size
- 1-10
How to pitch Impact Rooms
The founders who hear back from Impact Rooms lead with traction and a clear ask that matches its stage, not a generic mass email. Build a targeted, verified list, write a personalized note, and track who opens it, all in one place.
Connect with Impact Rooms
About this profile
This profile is part of Round Funded, an investor database and outreach platform for founders. It covers 60,000+ active VCs, angels, family offices and accelerators with verified contacts, lets you send pitches from your own Gmail, and includes a free Data Room for your raise. How this data is built.
Cite this page
Round Funded. "Impact Rooms." Round Funded investor database, updated October 19, 2026.
Stable URL, it will not change: https://www.roundfunded.com/en/vc/impact-rooms
Frequently Asked Questions
What is Impact Rooms?
Impact Rooms is a venture capital firm based in Mexico City, Mexico. Round Funded tracks its focus, stage, and activity alongside thousands of active investors.
Where is Impact Rooms based?
Impact Rooms is based in Mexico City, Mexico. You can reach out from anywhere with a pitch that matches its focus.
How do I contact Impact Rooms?
Unlock a verified email for Impact Rooms and reach out with a personalized pitch on Round Funded. We show only deliverable contacts, so your outreach does not bounce.
What is Round Funded?
Round Funded is an investor database and outreach platform for startup founders. It lists 60,000+ active investors with verified contacts, filtered to recent investment activity, and lets founders send personalized pitches from their own Gmail, track replies, and share a free Data Room. Round+ starts at $99 per month with a 3-day trial.